Pressroom
-
Biosimilar Drugs Underutilized Due to Commercial Insurance Restrictions
The first study to examine biosimilar drivers finds commercial insurers limit use in almost 20% of cases.
Categorized in -
Schaeffer Research Director Testifies at Congressional Hearing on Biomedical Innovation and Patient Access
Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.
-
Medicare Coverage of Weight Loss Drugs Could Significantly Reduce Costs
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
Categorized in -
New Schaeffer White Paper Offers Solutions to Ensure Greater Patient Access to Prescription Drugs
The researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
Categorized in -
Medicare Advantage Enrollment Outpaces —and Nearly Overcomes— Traditional Medicare, New USC Study Finds
Medicare Advantage plans have seen a more than 300% increase in enrollment—with payment policy yet to catch up.
Categorized in -
False Confidence in Blood Pressure Knowledge Undermines Intentions to Seek Care
Most Americans don’t know the meaning of 120-80 mm Hg, but think they do.
Categorized in -
New Randomized Trial Shows Simple Letters Promote Better-Informed Opioid Prescribing
Letters successfully encouraged clinicians to check patients’ prescribing records, says study co-author Mireille Jacobson.
Categorized in -
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Categorized in -
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Categorized in -
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.
Categorized in